Twist Bioscience Reports Fiscal Second Quarter 2023 Financia

– Record revenue of $60.2M in 2QFY23; up 25% over $48.1M in 2QFY22 –


– Orders increased to $64.2M in 2QFY23; up 17% over 2QFY22 –


– Decisive Actions to Accelerate... | May 5, 2023

Related Keywords

Boston , Massachusetts , United States , Facebook Linkedin Youtube , Emilym Leproust , Exchange Commission On , Plex Library Prep Kit , Company Investor Relations , Twist Biopharma Solutions , Biopharma Solutions , Development Expenses , Twist Bioscience Corporation , South San Francisco , South San , Administrative Expenses , Chimeric Antigen Receptor , Faster Insights , Whole Genome Sequencing , Send Cash , Accounting Standards Codification , Investor Relations , Private Securities Litigation Reform Act , Twist Bioscience , Quarterly Report , Exchange Commission , Consolidated Statements , Twist Bioscience Corporation Stock Exchange , News , Information , Press Release , Record , Revenue , F , N , P , Dover , 1qfy22 , Borders , Ncreased , O , Decisive , Actions , O Twst Us90184d1000 ,